Nifty
Sensex
:
:
8083.80
27590.95
-170.00 (-2.06%)
-674.36 (-2.39%)

Pharmaceuticals & Drugs

Rating :
83/99

BSE: 500660 | NSE: GLAXO

1224.20
03-Apr-2020
  • Open
  • High
  • Low
  • Previous Close
  •  1230.00
  •  1248.00
  •  1155.00
  •  1210.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  64230
  •  763.01
  •  1748.00
  •  962.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 20,718.36
  • 262.62
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 19,547.60
  • 1.64%
  • 12.30

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.66%
  • 10.97%
  • FII
  • DII
  • Others
  • 0.51%
  • 3.97%
  • 8.89%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.44
  • 2.46

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 0.90
  • 7.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -1.34
  • 9.76

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 57.58
  • 61.55
  • 61.98

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.89
  • 12.74
  • 11.01

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.15
  • 37.93
  • 37.32

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
778.59
825.35
-5.67%
882.02
0.00
0
787.97
0.00
0
751.13
0.00
0
Expenses
654.20
688.20
-4.94%
688.01
0.00
0
622.68
0.00
0
588.08
0.00
0
EBITDA
124.39
137.15
-9.30%
194.01
0.00
0
165.29
0.00
0
163.05
0.00
0
EBIDTM
15.98%
16.62%
22.00%
0.00%
20.98%
0.00%
21.71%
0.00%
Other Income
16.50
16.58
-0.48%
15.88
0.00
0
30.81
0.00
0
52.72
0.00
0
Interest
2.98
0.05
5,860.00%
0.92
0.00
0
0.93
0.00
0
0.08
0.00
0
Depreciation
18.33
12.04
52.24%
22.70
0.00
0
19.06
0.00
0
13.68
0.00
0
PBT
-634.32
170.48
-
587.41
0.00
0
176.11
0.00
0
198.82
0.00
0
Tax
26.84
56.81
-52.75%
84.66
0.00
0
62.57
0.00
0
75.06
0.00
0
PAT
-661.16
113.67
-
502.75
0.00
0
113.54
0.00
0
123.76
0.00
0
PATM
-84.92%
13.77%
57.00%
0.00%
14.41%
0.00%
16.48%
0.00%
EPS
-39.03
6.71
-
29.68
0.00
0
6.70
0.00
0
7.31
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Net Sales
3,199.71
3,128.12
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
2,455.38
2,151.06
1,907.77
Net Sales Growth
287.68%
8.94%
-1.27%
2.49%
-15.61%
28.96%
-3.13%
9.64%
14.15%
12.75%
 
Cost Of Goods Sold
1,333.50
1,358.03
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
923.50
785.73
700.01
Gross Profit
1,866.21
1,770.09
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
1,531.87
1,365.33
1,207.75
GP Margin
58.32%
56.59%
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
62.39%
63.47%
63.31%
Total Expenditure
2,552.97
2,527.32
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
1,693.90
1,478.25
1,324.67
Power & Fuel Cost
-
27.94
26.44
27.82
25.97
31.17
23.85
22.50
26.70
26.75
24.66
% Of Sales
-
0.89%
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
1.09%
1.24%
1.29%
Employee Cost
-
537.20
523.40
483.01
443.37
493.02
362.05
295.52
278.36
234.53
203.97
% Of Sales
-
17.17%
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
11.34%
10.90%
10.69%
Manufacturing Exp.
-
115.55
110.55
108.26
118.09
367.24
127.78
113.62
111.44
67.51
60.08
% Of Sales
-
3.69%
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
4.54%
3.14%
3.15%
General & Admin Exp.
-
178.60
204.45
195.08
154.85
178.21
135.34
126.10
108.51
145.09
130.13
% Of Sales
-
5.71%
7.12%
6.71%
5.46%
5.30%
5.19%
4.68%
4.42%
6.75%
6.82%
Selling & Distn. Exp.
-
202.81
154.38
178.91
164.47
222.31
186.23
160.74
157.60
140.85
131.33
% Of Sales
-
6.48%
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
6.42%
6.55%
6.88%
Miscellaneous Exp.
-
107.20
105.12
98.67
127.99
168.72
117.55
96.17
87.78
72.33
131.33
% Of Sales
-
3.43%
3.66%
3.39%
4.51%
5.02%
4.51%
3.57%
3.58%
3.36%
3.84%
EBITDA
646.74
600.80
505.79
418.98
478.27
574.58
483.21
776.84
761.48
672.81
583.10
EBITDA Margin
20.21%
19.21%
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
31.01%
31.28%
30.56%
Other Income
115.91
102.32
54.54
73.07
123.18
258.80
222.30
223.90
186.59
217.06
194.80
Interest
4.91
0.55
0.19
0.25
0.42
0.47
0.33
0.33
0.33
0.62
0.37
Depreciation
73.77
48.59
37.99
26.35
24.95
25.35
19.88
17.84
20.41
17.63
16.37
PBT
328.02
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
Tax
249.13
237.28
189.24
174.37
202.25
279.27
229.78
272.48
176.20
293.35
260.70
Tax Rate
75.95%
34.76%
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
29.13%
33.66%
34.25%
PAT
78.89
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
PAT before Minority Interest
78.89
445.39
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
2.47%
14.24%
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
17.46%
26.88%
26.23%
PAT Growth
-30.60%
26.99%
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
31.10%
-25.88%
15.55%
 
Unadjusted EPS
4.66
26.29
20.70
39.76
44.41
56.24
56.87
66.34
50.60
66.18
59.96

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Shareholder's Funds
2,139.83
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
1,935.70
1,951.58
1,786.09
Share Capital
169.41
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
1,970.42
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
1,851.00
1,866.88
1,701.39
Non-Current Liabilities
2,860.37
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
172.78
-51.43
-39.47
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.18
0.58
0.99
1.60
2.63
3.61
4.14
4.59
5.16
5.42
Long Term Provisions
2,920.20
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
224.81
0.00
0.00
Current Liabilities
2,804.07
2,948.98
881.09
783.63
1,106.55
888.91
836.40
859.59
3,179.07
2,718.89
Trade Payables
405.81
505.86
278.93
327.74
308.04
285.63
237.37
200.58
334.36
294.42
Other Current Liabilities
802.71
842.35
390.47
202.82
130.09
84.13
86.82
67.25
12.60
22.78
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
1,595.54
1,600.77
211.69
253.08
668.42
519.15
512.21
591.77
2,832.12
2,401.69
Total Liabilities
7,804.27
7,638.78
6,587.65
6,465.20
3,132.57
3,037.23
3,001.68
2,968.07
5,079.22
4,465.51
Net Block
429.99
322.81
252.71
204.04
123.08
100.09
89.42
99.15
108.95
92.83
Gross Block
559.05
405.89
299.09
228.36
363.34
343.22
316.18
315.80
362.54
333.32
Accumulated Depreciation
129.06
83.08
46.38
24.32
240.26
243.13
226.76
216.65
253.59
240.49
Non Current Assets
4,445.06
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
363.01
235.57
262.64
Capital Work in Progress
1,002.64
922.90
605.46
267.67
115.22
61.86
43.79
16.19
8.72
21.36
Non Current Investment
1.69
1.84
5.40
6.04
0.06
0.06
10.06
54.98
117.90
148.46
Long Term Loans & Adv.
3,002.88
2,850.97
3,882.49
3,609.24
296.09
237.73
194.55
157.01
0.00
0.00
Other Non Current Assets
7.84
4.75
6.47
0.06
11.13
13.55
17.19
35.68
0.00
0.00
Current Assets
3,359.21
3,535.52
1,835.10
2,378.15
2,586.98
2,623.94
2,646.67
2,605.06
4,843.65
4,202.88
Current Investments
0.00
0.00
0.00
0.00
0.00
10.00
44.91
57.21
0.00
0.00
Inventories
486.49
500.18
425.80
525.87
375.58
346.97
285.15
333.44
285.55
257.30
Sundry Debtors
120.49
146.96
170.80
126.56
100.32
96.39
115.90
85.31
47.03
53.73
Cash & Bank
1,171.35
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
2,014.36
2,002.89
1,733.90
Other Current Assets
1,580.88
78.72
106.70
23.24
200.47
128.99
133.94
114.74
2,508.18
2,157.95
Short Term Loans & Adv.
1,468.58
1,513.25
232.20
310.58
112.04
71.19
58.18
50.12
2,454.34
2,127.55
Net Current Assets
555.14
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
1,745.46
1,664.58
1,483.98
Total Assets
7,804.27
7,638.78
6,587.64
6,465.20
3,132.56
3,037.24
3,001.68
2,968.07
5,079.22
4,465.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Cash From Operating Activity
399.38
472.80
234.37
138.90
337.64
281.31
313.59
335.37
479.36
511.51
PBT
653.97
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
Adjustment
-31.36
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
-139.38
-89.96
-69.78
Changes in Working Capital
-4.19
164.56
-26.69
-124.41
-36.90
11.45
56.35
-73.09
12.66
20.47
Cash after chg. in Working capital
618.41
674.55
392.29
355.67
597.00
540.37
879.30
714.86
794.32
711.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-204.34
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
-316.53
-313.89
-185.38
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
-14.69
0.25
2.67
-10.82
-6.93
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-143.34
-104.19
300.64
499.02
180.01
188.98
-109.65
358.03
86.76
660.78
Net Fixed Assets
-232.90
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
39.27
-16.58
-18.44
Net Investments
23.26
3.56
0.64
-5.96
10.00
44.92
57.21
0.55
30.56
560.97
Others
66.30
316.49
708.52
566.60
243.48
189.17
-138.88
318.21
72.78
118.25
Cash from Financing Activity
-358.36
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
-394.81
-297.15
-394.84
Net Cash Inflow / Outflow
-102.33
61.97
24.24
-0.42
20.66
-23.85
-236.69
298.59
268.97
777.45
Opening Cash & Equivalents
201.10
139.13
114.89
115.30
94.93
137.67
374.36
75.77
1,734.03
956.58
Closing Cash & Equivalent
98.78
201.10
139.13
114.89
115.59
113.82
137.67
374.36
2,003.01
1,734.03

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Book Value (Rs.)
126.31
121.44
118.46
128.88
107.96
117.45
118.46
114.26
115.20
105.43
ROA
5.77%
4.93%
5.16%
7.84%
15.44%
15.95%
18.82%
10.65%
12.12%
11.74%
ROE
21.22%
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
22.05%
30.94%
29.77%
ROCE
32.54%
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
31.05%
46.54%
45.16%
Fixed Asset Turnover
6.48
8.21
11.38
9.59
9.82
8.13
8.74
7.40
6.31
5.91
Receivable days
15.60
20.03
18.09
14.59
10.35
14.45
13.29
9.62
8.38
10.45
Inventory Days
57.56
58.36
57.89
57.97
38.01
43.02
40.86
45.01
45.13
45.88
Payable days
73.24
66.07
51.56
53.81
43.72
49.18
47.40
62.14
88.58
85.41
Cash Conversion Cycle
-0.07
12.32
24.42
18.75
4.64
8.28
6.75
-7.51
-35.07
-29.09
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
1232.59
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59
1848.25
1403.44
2037.83

News Update:


  • Glaxosmithkline Pharmaceuticals reports consolidated net loss of Rs 661 crore in Q3
    4th Feb 2020, 10:08 AM

    Total consolidated income of the company decreased by 5.56% at Rs 795.09 crore for Q3FY20

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.